HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Yong Xiao Wang
Keynote Presentation (In-Person)
Yong Xiao Wang, Albany Medical College, United States

Alzheimer’s disease (AD) and AD-related dementias (ADRD) are the common incurable neurodegenerative conditions characterized by progressive cognitive deterioration, memory decline and even death. The major forms of ADRD include vascular contributions to cognitive impai [....] » Read More

Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Jacqueline Tuppen
Keynote Presentation (In-Person)
Jacqueline Tuppen, Cogs Club, United Kingdom

The NICE guidelines in November 2006 stated: "People with mild / moderate dementia of all types should be given the opportunity to participate in a structured group cognitive stimulation programme. This should be commissioned and provided by a range of health and social c [....] » Read More

Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Denise Dupree
Oral Presentation (In-Person)
Denise Dupree, Homewatch Care Givers of ST Pete Beach, United States

Aging in place is the term used to describe seniors who are able to live independently in their own homes for as long as possible. The reasons for aging in place vary from individual to individual. Some seniors want to remain active and independent in their own home for as long a [....] » Read More

Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Constantina Mizis
Oral Presentation (In-Person)
Constantina Mizis, The Latino Alzheimer’s and Memory Disorders Alliance, United States

Statement of the Problem: More than 5 million of Americans are living with Alzheimer’s, and that number is expected to increase to 14 million in 2050. According to UsAgainstAlz., Alzheimer’s will cost Latino families a cumulative $2.3 trillion by 2060 and the number o [....] » Read More

Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Paul Y Song
Oral Presentation (In-Person)
Paul Y Song, NKGen Biotech, United States

Background: Alzheimer’s Disease (AD) remains a neurodegenerative diseases with little to no disease modifying treatments. As more evidence emerges on how misfolded amyloid deposits elicit a cascade of autoreactive neuroinflammation and damage, it is clear that removing thes [....] » Read More

Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Cheng Pak Wing Calvin
Oral Presentation (In-Person)
Cheng Pak Wing Calvin, The University of Hong Kong, Hong Kong

There are limited effectiveness and potential alarming side effects of pharmacological approach for the Neurocognitive disorder (NCD). Transcranial pulse stimulation (TPS) has been shown to be a potential tool to bring the benefit. We have conducted an open-label study. Older adu [....] » Read More

Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Akankunda Veronicah
Oral Presentation (In-Person)
Akankunda Veronicah, Executive Director, Uganda

Dementia is an age mental disorder that makes victims lose normal functionality that need delicate attention. It has been technically defined as a clinical syndrome characterised by a cluster of symptoms manifested by difficulties in memory, disturbances in speech and a [....] » Read More

Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Kaoru Sakatani
Keynote Presentation (Virtual)
Kaoru Sakatani, The University of Tokyo, Japan

For effective treatment and prevention of dementia, it is important to develop an objective, accurate, and inexpensive screening test for early diagnosis of cognitive impairment. To resolve these issues, we have developed a deep neural network (DNN) model that can estimate risk o [....] » Read More

Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Mario Allegra
Keynote Presentation (Virtual)
Mario Allegra, University of Palermo, Italy

Overnutrition and modern diets containing high proportions of saturated fat are amongst the major factors responsible for the development of low-grade, systemic, chronic inflammation, dyslipidaemia and hyperglycaemia. Interestingly enough, recent studies started to recognize oxid [....] » Read More

Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Jun Hua
Keynote Presentation (Virtual)
Jun Hua, Johns Hopkins University School of Medicine, United States

Neurovascular abnormalities play a critical role in the pathogenesis of neurodegenerative diseases. Impaired small blood vessels and CSF clearance through cerebral lymphatic vessels are often observed in such diseases. Noninvasive imaging biomarkers can provide a powerful tool fo [....] » Read More

Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Esraa Askar
Oral Presentation (Virtual)
Esraa Askar, Forest Hills Hospital, United States

Background: Corticobasal degeneration (CBD) is a rare neurodegenerative tauopathy primarily affecting the cerebral cortex and basal ganglia, often featuring cognitive decline and parkinsonism. With no proven treatments, management goals include improving patients' quality [....] » Read More

Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Suren A Tatulian
Oral Presentation (Virtual)
Suren A Tatulian, University of Central Florida, United States

There are around 35 million individuals affected by Alzheimer’s disease (AD) dementia worldwide, and currently there are no effective disease-modifying medicines for AD. During the last 2.5 decades, four FDA-approved AD drugs, i.e., donepezil, rivastigmine, galantamine, and [....] » Read More

Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Huiyu Zhou
Oral Presentation (Virtual)
Huiyu Zhou, University of Leicester, United Kingdom

The behavioural phenotype research can be of great importance as the first symptom of neurodegenerative disorders is often identifiable through subtle changes in day-to-day human behaviors. Because of the similarity and homology between humans and mice, modelling mouse behaviour [....] » Read More

Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Clare Cromwell
Oral Presentation (Virtual)
Clare Cromwell, Cork University Maternity Hospital, Ireland

As GPs and Menopause Specialists brain fog is a frequent topic and often the most distressing and debilitating symptom expressed in consultation. It can present in a way that we don’t recognise and the diagnosis is too easily missed. It can present in primary care, neurolog [....] » Read More

Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Marco Ruggiero
Oral Presentation (Virtual)
Marco Ruggiero, Silver Spring Sagl, Switzerland

The degree of brain entropy (BEN) is associated with different levels of consciousness. The entropic brain hypothesis contemplates that, within upper and lower cutoff points, beyond which consciousness may be significantly reduced or absent, the entropy of spontaneous cerebral ac [....] » Read More

Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Sergio L Schmidt
Oral Presentation (Virtual)
Sergio L Schmidt, Universidade Federal Do Estado Do Rio De Janeiro, Brazil

Objective: We aimed to analyze the discriminative power of a culture-free Go/No-Go task by comparing three groups: cognitively unimpaired healthy elderly, Mild Cognitive Impaired subjects (MCI), and early Alzheimer´s disease patients (AD). For  the three groups th [....] » Read More

Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Cristina Carvalho
Oral Presentation (Virtual)
Cristina Carvalho, University of Coimbra, Portugal

Type 2 diabetes (T2D) is a chronic metabolic disorder that significantly increases the risk of dementia, particularly Alzheimer’s disease (AD). It is of utmost importance to decipher the mechanisms underlying T2D-associated brain damage to facilitate the development of effe [....] » Read More

Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Bitra Veera Raghavulu
Oral Presentation (Virtual)
Bitra Veera Raghavulu, University of Botswana, Botswana

Mechanistic/mammalian target of rapamycin (mTOR) belongs to the phosphatidylinositol kinase-related kinase (PIKK) family. mTOR signaling is required for the commencement of essential cell functions including autophagy. mTOR primarily governs cell growth in response to favorable n [....] » Read More

Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Rui Yuan Pan
Oral Presentation (Virtual)
Rui Yuan Pan, Beijing Institute of Basic Medical Sciences, China

Alzheimer’s disease (AD) is the most common form of dementia without effective clinical treatment. Here, we show that intermittent fasting (IF) improves cognitive functions and AD-like pathology in a transgenic AD mouse model (5XFAD). IF alters gut microbial composition wit [....] » Read More

Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Kai Wen He
Oral Presentation (Virtual)
Kai Wen He, Interdisciplinary Research Center on Biology and Chemistry, China

Sleep disorders are commonly found in Alzheimer's disease (AD) patients, which can occur at very early stage of AD and are proposed as potent risk factors for disease onset and progression. What may cause these early-onset sleep deficits remains unexplored. Here by thoroughly [....] » Read More

Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Byung Hee Han
Poster Presentation (Virtual)
Byung Hee Han, Kai-i Company, Korea, Republic of

Background: Early detection of dementia is very important for improving the quality of life of patients and their families and providing appropriate medical interventions. The Korean Dementia Screening Questionnaire (KDSQ) was developed by Dong Won Yang et al. in 2002 and is used [....] » Read More

Watsapp